SI-BONE, Inc. (SIBN) earnings
SIBN earnings moved a median of 0.00% by the close. Quarterly and annual SIBN reports and results, each read against the price at its own news timestamp. Back to the SIBN overview →
31 measured SIBN earnings events.
Where these SIBN earnings landedvs 31 measured SIBN earnings reactions
| Middle 50% of SIBN earnings reactions | -3.11% to +4.30% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 SIBN earnings events with a measured close landed between -3.11% and +4.30%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q SI-BONE, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.10% | -0.33% | |
| SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance | Press release | +9.14% | +4.06% | |
| SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026 | Press release | +0.06% | +0.89% | |
| Form 10-Q SI-BONE, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.10% | +6.43% | |
| SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance | Press release | -3.10% | +6.43% | |
| SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026 | Press release | +0.10% | -3.69% | |
| Form 10-K SI-BONE, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.13% | +5.05% | |
| SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance | Press release | -6.10% | -6.77% | |
| Form 10-Q SI-BONE, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.95% | +7.43% | |
| SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance | Press release | +1.95% | +7.43% | |
| SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025 | Press release | +0.53% | +1.97% | |
| Form 10-Q SI-BONE, Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.05% | +3.27% | |
| SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance | Press release | -6.82% | -7.19% | |
| SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025 | Press release | -0.75% | -2.93% | |
| Form 10-Q SI-BONE, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.96% | +4.99% | |
| SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance | Press release | -5.03% | +2.68% | |
| SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025 | Press release | +2.00% | -1.44% | |
| Form 10-K SI-BONE, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.55% | +0.61% | |
| SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance | Press release | -5.81% | -3.51% | |
| Form 10-Q SI-BONE, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.07% | -3.24% | |
| SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance | Press release | +1.07% | -3.24% | |
| SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024 | Press release | +1.09% | -1.16% | |
| Form 10-Q SI-BONE, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.04% | +0.00% | |
| SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024 | Press release | -0.89% | -6.08% | |
| SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024 | Press release | -0.13% | +7.54% | |
| Form 10-Q SI-BONE, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.26% | -2.98% | |
| SI-BONE, Inc. Reports Financial Results for the First Quarter 2024 | Press release | -0.53% | +4.53% | |
| SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024 | Press release | -0.99% | +0.99% | |
| Form 10-K SI-BONE, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.31% | -1.75% | |
| Form 10-Q SI-BONE, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.49% | -1.51% | |
| SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance | Press release | +0.17% | -4.89% |
Keep exploring
More SIBN: analyst actions → · SEC filings → · SIBN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| National HealthCare Corporation (NHC) | 310 | 0.00% | 49% |
| NeuroOne Medical Technologies Corporation (NMTC) | 310 | -0.19% | 41% |
| Galectin Therapeutics Inc. (GALT) | 309 | 0.00% | 50% |
| MENLO THERAPEUTICS INC COMMON (MNLO) | 308 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.